Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongluo Qutong ointment for pain in cervical radiculopathy
ChiCTR2200062271Phase 4Not yet recruiting
- Sponsor
- Gansu Second Provincial People's Hospital
- Start
- Jul 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Tongluo Qutong in cervical spondylotic radiculopathy (CSR) (2 arms), sponsored by Gansu Second Provincial People's Hospital. Primary endpoint: Visual analogue scale pain score. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
Tongluo Qutong
03
Conditions
cervical spondylotic radiculopathy (CSR)
Beyond the preview
Go deeper on ChiCTR2200062271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062271.